Zynex Poised for New Future with Resolution of Federal Investigation
New Zynex Leadership Responds to Indictment of Former Executives
Zynex Inc (ZYXI) Q3 2025 Earnings Call Highlights: Navigating Financial Challenges Amid ...
Zynex, Inc. (ZYXI) Q3 2025 Earnings Call Prepared Remarks Transcript
Zynex Reports Third Quarter 2025 Financial Results
Zynex announces series of strategic initiatives, to evaluate alternatives
Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee
Zynex Sets Third Quarter 2025 Earnings Call
Global Women’s Health Rehabilitation Products Market Size/Share Worth USD 9.8 Billion by 2034 at a 6.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles
Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates
Zynex, Inc. (ZYXI) Q2 2025 Earnings Call Transcript
Zynex Reports Second Quarter 2025 Financial Results
Zynex Sets Second Quarter 2025 Earnings Call
Tricare Temporary Payment Suspension Update
Zynex Announces Steven Dyson as New CEO
Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis
Here’s Why Zynex (ZYXI) Fell in Q1
Zynex announces submission of 510(k) application for laser pulse oximeter
Zynex Submits FDA Application for Its NiCO Laser Pulse Oximeter
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.